Company Search:
Advanced Search
Sponsored Links
Genetic Technologies Limited - ADR Company Snapshot
Genetic Technologies Limited operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Technologies Limited with three other pharmaceutical manufacturers in North America: Premier Biomedical Inc (2019 sales of $14,281.00 ), Seneca Biopharma IncXX ($15,394.00 ), and Phio Pharmaceuticals Corp ($21,000.00 ).

Sales Analysis. Sales fell dramatically in 2019: Genetic Technologies Limited reported sales of $18,185.08 for the fiscal year ending June of 2019. This represents a sharp decrease of 87.6% versus 2018, when the company's sales were $146,384.18 .
  Stock Performance Chart for Genetic Technologies Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 4.11
(Figures in U.S. Dollars)
1 Week -1.4%   13 Weeks 74.9%  
4 Weeks 94.8%   52 Weeks 85.8%  
Genetic Technologies Limited - ADR Key Data:
  Ticker: GENE Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2019 Sales 18,185
(Year Ending Jan 2020).
Employees: 56
  Currency: U.S. Dollars Market Cap: 111,329,876
  Fiscal Yr Ends: June Shares Outstanding: 27,087,561
  Share Type: Ordinary Closely Held Shares: 4,890,275
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.